Avicanna Announces Sponsorship of Pilot Phase II Clinical Study Osteoarthritis Pain
Globenewswire·2025-05-20 11:45
Multi-centre, blinded, randomized placebo-controlled investigator initiated study, to be led by Dr. Hance Clarke and conducted at University Health Network For more information about Avicanna, visit our website or contact Ivana Maric by email at info@avicanna.com. TORONTO, May 20, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or "Company") (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-base ...